Proteomics International Partners with inVentiv Health Clinical - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Proteomics International Partners with inVentiv Health Clinical

Source: Applied Clinical Trials

Proteomics International, a pretomics laboratory, has signed a collaborative agreement with inVentiv Health Clinical, provider of global research and bioanalytical services, with the intention of helping streamline the process from characterization to clinical trials.

Proteomics International's structural characterization and QC testing of proposed and referenced products with an advanced suite of scientific instrumentation complement inVentiv Health’s array of bioanalytical capabilities from clinical development through commercialization in support of biosimilar development.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here